StockChartsAI.com
All Chart Prices Delayed at least 15 minutesBefore accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 6.9
Power Rank trend -> Falling
03/27/2025 16:10:00 EST
GlaxoSmithKline PLC ADR (GSK)
Industry: Drug Manufacturers - General
Follow @stockchartsai on TwitterPrice Support Resistance
In the past 20 trading days, GSK has been trading in a range between $40.39 and $37.30 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
GSK is trading between resistance at $40.25 about 4% to the upside and support at $37.40 -3% to the downside. If it can break above the resistance, it could have some more upside to the next line of resistance at $44.26, about a 15% move. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
Upside / Downside Potential
GlaxoSmithKline PLC ADR $GSK entered a Green zone 48 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $45.0743, a potential upside of 17.66% from the recent price of 38.31. The stock is trading 15.82% (potential upside) below its 52 week high of $44.37 and 22.12 % (potential downside) above its 52 week low of $31.37 - based on the recent price.
Company Summary
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, polio, influenza, and pandemic vaccines.
News
| Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 7, 2025 in GSK plc Lawsuit - GSK NEW YORK, NY / ACCESS Newswire / March 27, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=139319&wire=1 or contact Joseph E. Levi, Esq. Source: Accesswire Thu, 27 Mar 2025 20:00:00 -0400 Sentiment: Neutral |
| GSK plc Investors: Please contact the Portnoy Law Firm to recover your losses. April 7, 2025 Deadline to file Lead Plaintiff Motion Investors can contact the law firm at no cost to learn more about recovering their losses Investors can contact the law firm at no cost to learn more about recovering their losses Source: GlobeNewsWire Thu, 27 Mar 2025 19:31:00 -0400 Sentiment: Neutral |
| Class Action Filed Against GSK plc (GSK) Seeking Recovery for Investors - Contact Levi & Korsinsky NEW YORK, NY / ACCESS Newswire / March 27, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=139316&wire=1 or contact Joseph E. Levi, Esq. Source: Accesswire Thu, 27 Mar 2025 19:15:00 -0400 Sentiment: Neutral |
| GSK FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action – GSK NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts (“ADRs”) of GSK plc (NYSE: GSK) between February 5, 2020 and August 14, 2022, both dates inclusive (the “Class Period”), of the important April 7, 2025 lead plaintiff deadline. Source: GlobeNewsWire Thu, 27 Mar 2025 18:51:00 -0400 Sentiment: Neutral |
| GSK plc Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK NEW YORK, NY / ACCESS Newswire / March 27, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=139279&wire=1 or contact Joseph E. Levi, Esq. Source: Accesswire Thu, 27 Mar 2025 18:45:00 -0400 Sentiment: Neutral |
Technicals 52 Week Hi: 44.3682 52 Week Low: 31.3709 Beta: 0.286 50 Day MA: 37.04 200 Day MA: 38.0306 Earnings / Revenue Trends Qtr Earnings Growth YOY: 0.173 Qtr Revenue Growth YOY: 0.008 Forward PE: 8.6806 Trailing PE: 23.9255